Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on March 11, 2025

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

HOLLISTER, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Pluristyx's PluriFreeze™ product line, a …

RevMaxx Enhances Medical Scribe Capabilities with New Features

RevMaxx Enhances Medical Scribe Capabilities with New Features

RevMaxx has introduced new AI-powered medical scribing features designed to streamline clinical documentation and reduce physician burnout. TAMPA, FL, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- Physician burnout is at an all-time high, with …

Celiveo 365 applies AI-DLP Data Loss Protection to Microsoft Universal Print Cloud print management

Celiveo 365 applies AI-DLP Data Loss Protection to Microsoft Universal Print Cloud print management

Celiveo 365 integrates seamlessly with Microsoft Universal Print, adding a suite of Enterprise features now including AI-based DLP protecting against data leak MERIDIAN, ID, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- Celiveo 365, a leader in …

Behavidence Launches New Consumer App to Transform Mental Wellness with Playful and Seamless Management

Behavidence Launches New Consumer App to Transform Mental Wellness with Playful and Seamless Management

Behavidence launches a new version of their consumer app for mental wellness tracking, reducing stigma …

INDIGO Biosciences Launches Dopamine Receptor D1 Reporter Assay for Neurological and Psychiatric Research

INDIGO Biosciences Launches Dopamine Receptor D1 Reporter Assay for Neurological and Psychiatric Research

New Cell-Based Assay Supports Drug Discovery for DRD1-Targeted Therapies STATE COLLEGE, PA, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- INDIGO Biosciences, a premier provider of cell-based assay solutions, has introduced its Human Dopamine …

Executive Producers of SGTI Documentary Series Finalize Business Selection and Begin Outreach

Executive Producers of SGTI Documentary Series Finalize Business Selection and Begin Outreach

LONDON, UNITED KINGDOM, March 11, 2025 /⁨EINPresswire.com⁩/ -- The highly anticipated Sustainable Global Trade Initiative (SGTI) Documentary Series has reached a key milestone as its executive producers finalize its carefully curated list of businesses …

Florida Mesothelioma Victims Center Strongly Recommends the Gori Law Firm to an Auto-Truck Mechanic with Recently Diagnosed Mesothelioma or Lung Cancer in Florida to Call the Gori Law Firm-Get Better Compensation

Florida Mesothelioma Victims Center Strongly Recommends the Gori Law Firm to an Auto-Truck Mechanic with Recently Diagnosed Mesothelioma or Lung Cancer in Florida to Call the Gori Law Firm-Get Better Compensation

TAMPA , FL, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center strongly recommends the Gori Law Firm for an auto-truck mechanic anywhere in Florida who has just been diagnosed with mesothelioma or lung cancer to …

Understanding the Sleep Aid Supplement Market : Key Trends and Insights

Understanding the Sleep Aid Supplement Market : Key Trends and Insights

WILMINGTON, DE, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- According to the report, the sleep aid supplement market was valued at $6.8 billion in 2023, and is estimated to reach $11.8 billion by 2034, growing at a CAGR of 5.1% from 2024 to 2034. …

SleepScore Labs’ Digital Sleep Program First to Demonstrate Positive Results in Randomized Controlled Trial

SleepScore Labs’ Digital Sleep Program First to Demonstrate Positive Results in Randomized Controlled Trial

Study of over 600 participants showed gains in sleep quality, using hyper-personalized sleep journeys and reimbursement in Germany’s health insurance system CARLSBAD, CA, UNITED STATES, March 11, 2025 /⁨EINPresswire.com⁩/ -- SleepScore Labs today …

Dein Schlaf by SleepScore wurde als erstes wissenschaftlich in einer großen Studie bestätigt

Dein Schlaf by SleepScore wurde als erstes wissenschaftlich in einer großen Studie bestätigt

Eine Studie mit über 600 Teilnehmern belegt verbesserten Schlaf und reduzierten Stress. DUBLIN, IRELAND, March 11, 2025 /⁨EINPresswire.com⁩/ -- Das digitale Schlafverbesserungsprogramm von SleepScore Labs hat seine Wirksamkeit in einer randomisierten …

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures

VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on opportunities within and outside of the cannabis industry, announces that it has entered …

Malatya Apricot | The Nutritional and Environmental Impact of Conventional Dried Apricots – Diced Dried Apricots

Malatya Apricot | The Nutritional and Environmental Impact of Conventional Dried Apricots – Diced Dried Apricots

Malatya Apricot | Conventional - Diced Dried Apricots Supplier and Exporter MALATYA, BATTALGAZI , TURKEY, March 11, 2025 /⁨EINPresswire.com⁩/ -- Dried apricots have long been a staple in diets across the world, known for their rich nutritional profile …

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar …

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic macular edema), neuro-ophthalmic (Privosegtor, OCS-05, in acute optic neuritis) and …

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 51,500 shares of …

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Raanana, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, today announced that it has filed its …

Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth …

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host conference call and webcast today, Mar. 11, 2025, at 4:30 p.m. …

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

ROCKVILLE, MD, March 11, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Acquired ImmPACT Bio and strengthened clinical pipeline with the addition of IMPT-314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate for the treatment of aggressive large B-cell lymphoma (LBCL) Presented positive initial data from …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service